About this Research Study
Pattern hair loss (PHL), also known as Androgenetic Alopecia (AGA), is a common dermatologic condition representing increased hair loss. The hair loss is more commonly seen in males than females and can be a source of frustration and self-consciousness.
Veradermics, Inc. is currently developing a novel compound for treatment of AGA in males and females. Part of the development program is to develop a patient reported outcome instrument to measure how pattern hair loss affects one’s life.
Qualified participants will complete a study survey that will take approximately 15 minutes to complete and will receive a stipend for their time.
Currently we are focusing on “males only”. To be able to participate you must have a clinical diagnosis of mild to moderate AGA and be fluent in English. If your pattern hair loss is similar to the images below, you may be eligible to participate in this research study.
For Males:
For Females
If you would like to be considered for this research study, please click the button below to complete the "Pre-Qualification Questionnaire". If you pre-qualify, one of our team members will be in contact with you soon.
Thank you for your interest in this study.